Article ID Journal Published Year Pages File Type
8217561 International Journal of Radiation Oncology*Biology*Physics 2015 8 Pages PDF
Abstract
SBRT for palliation of vertebral bone metastases is not cost-effective compared with EBRT at a $100,000 per QALY gained WTP threshold. However, if median survival is ≥11 months, SBRT costs ≤$100,000 per QALY gained, suggesting that selective SBRT use in patients with longer expected survival may be the most cost-effective approach.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Cost-Effectiveness Analysis of Single Fraction of Stereotactic Body Radiation Therapy Compared With Single Fraction of External Beam Radiation Therapy for Palliation of Vertebral Bone Metastases
Authors
, , , , , ,